The overall global ophthalmic pharmaceuticals market was estimated to be approximately $30 billion per year by Market Scope in 2018, and it is growing at approximately 5% per year. Corticosteroids remain the most commonly utilized anti-inflammatory drug in ophthalmology, and they have a broad array of indications. Topical steroids represent nearly $1 billion per year of sales in the U.S. alone and, using my best estimate, about $3 billion worldwide.
The most common use of a steroid in ophthalmology is to reduce postoperative inflammation and pain following cataract surgery, and (Read more...)
Uncategorized